Strategies for defending against GDPR fines

How can companies effectively protect themselves and defend against GDPR fines?  This session features attorneys with extensive frontline experience before German and French regulators. It covers the legal framework, provides effective defense strategies, and draws on actual case studies. Tim Wybitul, Partner, Latham & Watkins (Frankfurt) Myria Saarinen, Partner, Latham & Watkins (Paris) Room 302…

ePrivacy in the EU: The State of Play

Find out the latest regarding consent, cookies, profiling, and related issues. How is the ePrivacy Regulation developing? What are emerging relevant trends under the GDPR? What compliance steps should organizations be taking now? Colleen T. Brown, Partner, Sidley Austin LLP Peter Fatelnig, Minister-Counselor for Digital Economic Policy, Delegation of the European Union to the United…

Decentralizing Privacy: Data Protection Regulation in the Blockchain Era

At first glance, Blockchain technology and the GDPR seem irreconcilable. The GDPR was designed for an era where data are processed centrally. In contrast, blockchains are decentralized by their very essence. Immutability is considered to be one of Blockchain key characteristics, whereas GDPR promotes the right to be forgotten. At the same time, however, Blockchain…

Knowledge is Power and Portable: An In-Depth Look at the Right to Data Portability

The right to portability is one of the more complex rights provided under the GDPR and is often embedded into other privacy regimes in some form, perhaps even the California Consumer Privacy Act. It seems simple on its face, but once under review, the details of compliance can get complicated. Many companies worry about providing…

Anonymous and Pseudonymous Health Data: European and U.S. Perspectives

Different legal orders have taken varying approaches to regulating the collection, analysis and sharing of personally identifiable health data and to defining requirements for rendering health data anonymous.  This topic is of great importance for hospitals, pharmaceutical companies, and medical device manufacturers.  It is also raised by developments in the “internet of medical things.”  This session will consider…